MedPath

Study to Understand Risk Information to Support and Empower

Not Applicable
Conditions
Diabetes Mellitus, Type 2
Diabetes, Gestational
Interventions
Behavioral: Standard Health Information
Behavioral: Values Affirmation (VA)
Behavioral: Motivational Interviewing-based (MI)
Behavioral: Tailored Risk Information (TRI)
Behavioral: Action planning (AP)
Registration Number
NCT05752292
Lead Sponsor
University of California, Davis
Brief Summary

The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM). The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period. The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Female
Target Recruitment
2000
Inclusion Criteria
  • Current pregnancy complicated by gestational diabetes mellitus (GDM)
  • Age: 18 years and older
  • Contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center
  • Able to communicate in English
Exclusion Criteria
  • Diagnosis of diabetes before pregnancy
  • Maternal or infant current hospitalization
  • Pregnancy loss
  • History of eating disorder
  • Previously requested not to receive research invitations

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Condition 6Values Affirmation (VA)Standard health message + VA + MI
Condition 1Action planning (AP)Standard health message + VA + TRI + MI+ AP
Condition 7Action planning (AP)Standard health message + VA + AP
Condition 10Motivational Interviewing-based (MI)Standard health message + TRI + MI
Condition 1Values Affirmation (VA)Standard health message + VA + TRI + MI+ AP
Condition 1Tailored Risk Information (TRI)Standard health message + VA + TRI + MI+ AP
Condition 4Values Affirmation (VA)Standard health message + VA + TRI
Condition 1Standard Health InformationStandard health message + VA + TRI + MI+ AP
Condition 6Standard Health InformationStandard health message + VA + MI
Condition 1Motivational Interviewing-based (MI)Standard health message + VA + TRI + MI+ AP
Condition 3Values Affirmation (VA)Standard health message + VA + TRI + AP
Condition 3Action planning (AP)Standard health message + VA + TRI + AP
Condition 5Action planning (AP)Standard health message + VA + MI+ AP
Condition 2Values Affirmation (VA)Standard health message + VA + TRI + MI
Condition 2Motivational Interviewing-based (MI)Standard health message + VA + TRI + MI
Condition 3Standard Health InformationStandard health message + VA + TRI + AP
Condition 3Tailored Risk Information (TRI)Standard health message + VA + TRI + AP
Condition 2Standard Health InformationStandard health message + VA + TRI + MI
Condition 4Standard Health InformationStandard health message + VA + TRI
Condition 4Tailored Risk Information (TRI)Standard health message + VA + TRI
Condition 5Motivational Interviewing-based (MI)Standard health message + VA + MI+ AP
Condition 7Values Affirmation (VA)Standard health message + VA + AP
Condition 8Values Affirmation (VA)Standard health message + VA
Condition 9Motivational Interviewing-based (MI)Standard health message + TRI + MI+ AP
Condition 11Standard Health InformationStandard health message + TRI + AP
Condition 13Standard Health InformationStandard health message + MI+ AP
Condition 13Motivational Interviewing-based (MI)Standard health message + MI+ AP
Condition 2Tailored Risk Information (TRI)Standard health message + VA + TRI + MI
Condition 11Action planning (AP)Standard health message + TRI + AP
Condition 14Motivational Interviewing-based (MI)Standard health message + MI
Condition 15Standard Health InformationStandard health message + AP
Condition 7Standard Health InformationStandard health message + VA + AP
Condition 8Standard Health InformationStandard health message + VA
Condition 9Standard Health InformationStandard health message + TRI + MI+ AP
Condition 9Tailored Risk Information (TRI)Standard health message + TRI + MI+ AP
Condition 9Action planning (AP)Standard health message + TRI + MI+ AP
Condition 12Standard Health InformationStandard health message + TRI
Condition 13Action planning (AP)Standard health message + MI+ AP
Condition 5Standard Health InformationStandard health message + VA + MI+ AP
Condition 5Values Affirmation (VA)Standard health message + VA + MI+ AP
Condition 6Motivational Interviewing-based (MI)Standard health message + VA + MI
Condition 10Standard Health InformationStandard health message + TRI + MI
Condition 10Tailored Risk Information (TRI)Standard health message + TRI + MI
Condition 11Tailored Risk Information (TRI)Standard health message + TRI + AP
Condition 12Tailored Risk Information (TRI)Standard health message + TRI
Condition 14Standard Health InformationStandard health message + MI
Condition 15Action planning (AP)Standard health message + AP
Condition 16Standard Health InformationStandard health message
Primary Outcome Measures
NameTimeMethod
Completion of recommended postpartum diabetes screening.4-12 weeks postpartum

Completion of a 75-gram, 2-hour oral glucose tolerance test (OGTT)

Secondary Outcome Measures
NameTimeMethod
Completion of any recommended postpartum diabetes screening test.4-52 weeks postpartum

Completion of any screening test (OGTT, fasting plasma glucose, or HbA1c)

Uptake of a lifestyle program for diabetes prevention.4-52 weeks postpartum

Enrollment in a lifestyle program for diabetes prevention among women without type 2 diabetes mellitus according to any screening result

Trial Locations

Locations (1)

Kaiser Permanente Northern California

🇺🇸

Oakland, California, United States

© Copyright 2025. All Rights Reserved by MedPath